These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 4290762)

  • 1. Primary aldosteronism with unusual secretory pattern.
    Biglieri EG; Slaton PE; Kronfield SJ; Deck JB
    J Clin Endocrinol Metab; 1967 May; 27(5):715-21. PubMed ID: 4290762
    [No Abstract]   [Full Text] [Related]  

  • 2. Postoperative studies of adrenal function in primary aldosteronism.
    Biglieri EG; Slaton PE; Silen WS; Galante M; Forsham PH
    J Clin Endocrinol Metab; 1966 May; 26(5):553-8. PubMed ID: 4287160
    [No Abstract]   [Full Text] [Related]  

  • 3. Deoxycorticosterone production and regulation in man.
    Schambelan M; Biglieri EG
    J Clin Endocrinol Metab; 1972 Apr; 34(4):695-703. PubMed ID: 4335105
    [No Abstract]   [Full Text] [Related]  

  • 4. Effect of corticotropin on aldosterone excretion and plasma renin in normal subjects, in essential hypertension and in primary aldosteronism.
    Newton MA; Laragh JH
    J Clin Endocrinol Metab; 1968 Jul; 28(7):1006-13. PubMed ID: 4298942
    [No Abstract]   [Full Text] [Related]  

  • 5. Multiple plasma steroid responses to graded ACTH infusions in patients with primary aldosteronism.
    Guthrie GP
    J Lab Clin Med; 1981 Sep; 98(3):364-73. PubMed ID: 6267148
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Manipulation by corticotropin and cortisol of aldosterone secretion in primary aldosteronism.
    Newton MA; Laragh JH
    Arch Intern Med; 1969 Feb; 123(2):147-51. PubMed ID: 4303267
    [No Abstract]   [Full Text] [Related]  

  • 7. Effects of amino-glutethimide on adrenal function in man.
    Fishman LM; Liddle GW; Island DP; Fleischer N; Küchel O
    J Clin Endocrinol Metab; 1967 Apr; 27(4):481-90. PubMed ID: 4290077
    [No Abstract]   [Full Text] [Related]  

  • 8. Effects of glucocorticoid administration on aldosterone excretion and plasma renin in normal subjects, in essential hypertension and in primary aldosteronism.
    Newton MA; Laragh JH
    J Clin Endocrinol Metab; 1968 Jul; 28(7):1014-22. PubMed ID: 4298943
    [No Abstract]   [Full Text] [Related]  

  • 9. The effect of metyrapone on aldosterone secretion in man.
    Tucci JR; Espiner EA; Jagger PI; Lauler DP
    Acta Endocrinol (Copenh); 1967 Nov; 56(3):376-84. PubMed ID: 4293345
    [No Abstract]   [Full Text] [Related]  

  • 10. Dexamethasone-suppressible hyperaldosteronism.
    New MI; Siegal EJ; Peterson RE
    J Clin Endocrinol Metab; 1973 Jul; 37(1):93-100. PubMed ID: 4351777
    [No Abstract]   [Full Text] [Related]  

  • 11. Dexamethasone suppressible hyperaldosteronism: insights into adrenal physiology.
    Connell JM; Jardine A; Fraser R
    Adv Nephrol Necker Hosp; 1990; 19():69-77. PubMed ID: 2154082
    [No Abstract]   [Full Text] [Related]  

  • 12. Effect of adrenocorticotropin on desoxycorticosterone, corticosterone and aldosterone excretion.
    Biglieri EG; Shambelan M; Slaton PE
    J Clin Endocrinol Metab; 1969 Aug; 29(8):1090-101. PubMed ID: 4308415
    [No Abstract]   [Full Text] [Related]  

  • 13. Stimulation and suppression of aldosterone secretion in patients with an aldosterone-producing adenoma.
    Slaton PE; Schambelan M; Biglieri EG
    J Clin Endocrinol Metab; 1969 Feb; 29(2):239-50. PubMed ID: 4303579
    [No Abstract]   [Full Text] [Related]  

  • 14. Non-tumorous "primary" aldosteronism. I. Type relieved by glucocorticoid (glucocorticoid-remediable aldosteronism).
    Salti IS; Stiefel M; Ruse JL; Laidlaw JC
    Can Med Assoc J; 1969 Jul; 101(1):1-10. PubMed ID: 5793351
    [No Abstract]   [Full Text] [Related]  

  • 15. The intercurrent hypertension of primary aldosteronism.
    Biglieri EG; Schambelan M; Slaton PE; Stockigt JR
    Circ Res; 1970 Jul; 27(1 Suppl 1):195-202. PubMed ID: 5423298
    [No Abstract]   [Full Text] [Related]  

  • 16. Recurrent Cushing's syndrome associated with aldosterone deficiency.
    Hartog M; Harrison RJ; Joplin GF; Slater JD
    J Clin Endocrinol Metab; 1967 Jun; 27(6):843-8. PubMed ID: 4290736
    [No Abstract]   [Full Text] [Related]  

  • 17. Pseudo-primary aldosteronism. An entity distinct from true primary aldosteronism.
    Baer L; Sommers SC; Krakoff LR; Newton MA; Laragh JH
    Circ Res; 1970 Jul; 27(1 Suppl 1):203-20. PubMed ID: 4317860
    [No Abstract]   [Full Text] [Related]  

  • 18. Suppression of aldosterone by cyproheptadine in idiopathic aldosteronism.
    Gross MD; Grekin RJ; Gniadek TC; Villareal JZ
    N Engl J Med; 1981 Jul; 305(4):181-5. PubMed ID: 7017408
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pathogenesis of Bartter's syndrome.
    Goodman AD; Vagnucci AH; Hartroft PM
    N Engl J Med; 1969 Dec; 281(26):1435-9. PubMed ID: 4311054
    [No Abstract]   [Full Text] [Related]  

  • 20. Aldosterone secretory and glucocorticoid excretory responses to alpha 1-24 ACTH (Cortrosyn) in sodium-depleted normal man.
    Rayfield EJ; Rose LI; Dluhy RG; Williams GH
    J Clin Endocrinol Metab; 1973 Jan; 36(1):30-5. PubMed ID: 4344308
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.